Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Spain / NCT06669897
Recruiting Observational

Validation of a Questionnaire to Measure Cough Severity

NCT06669897 · tracked via the Priya Life Science Spain tracker
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase
Observational
Started
2025-05-01
Last updated
2025-09-15

Condition(s) studied

Cough

Investigational drug(s) / intervention(s)

Questionnaire

Questionnaire: Chronic cough questionnaire

Study summary

To design and validate a questionnaire that allows objective assessment of the severity of chronic cough

Eligibility

Sex
ALL
Min age
30 Years
Max age
99 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Aged between 30 and 99 years * Clinical diagnosis of chronic cough or healthy volunteers * Good understanding of Spanish Exclusion Criteria: * Non-Spanish-speaking patients * Inability to complete the questionnaires * Failure to sign the informed consent form

Primary outcome measure(s)

  • A questionnaire for assessing the severity of chronic cough — 1 year
    To design and validate a questionnaire to objectively assess the severity of chronic cough

Trial sites (6)

FacilityCityRegionStatus
Hospital Universitario Hermanos Trias y Pujol Badalona Barcelona Enrolling By Invitation
Hospital Univesitario de Bellvitge L'Hospitalet de Llobregat Barcelona Recruiting
Parc Taulí Hospital Universitari Sabadell Barcelona Recruiting
Hospital del Mar Barcelona Spain Recruiting
Hospital Clínic de Barcelona Barcelona Spain Recruiting
Hospital de la Santa Creu i Sant Pau. Carrer Mas Casanovas 90. Barcelona Spain Recruiting

More Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau trials in Spain

Aut-CARE Intervention to Improve Cognitive and Emotional Functioning in Young Adults on the Autism Spectrum Recruiting
Sleep Disorders in Hypothalamic and Pituitary Damage Recruiting
Deep Brain Stimulation Recovery in Treatment-Resistant Schizophrenia Active, not recruiting
Triple-A Barcelona Study Recruiting
Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06669897 on ClinicalTrials.gov ↗ ← All trials in Spain